definitive radiation

definitive radiation

Radiation oncology Administration of radiation as a sole or 1º therapy, usually for CA, with curative intent; DR doses average 40-50 Gy/4-5000 rads. See Radiation therapy.
References in periodicals archive ?
Management of prostate cancer recurrence after definitive radiation therapy.
These include adjuvant therapy for resected squamous cell carcinoma of the head and neck (new); local-regional therapy for resectable oropharyngeal squamous cell carcinomas; and retreatment of recurrent head and neck cancer after prior definitive radiation.
This study, along with other emerging studies, strongly suggests that statin use improves outcomes in patients treated with definitive radiation therapy," added Zelefsky.
At Hoag, we will deliver IORT as a definitive radiation treatment for selected patients, which means no additional radiation therapy is needed - a treatment approach that is gaining more traction in leading hospitals across the United States.
Post treatment assessment of response using FDG-PET-CT for patients treated with definitive radiation therapy for head and neck cancers.
Ishikawa H, Sakurai H, Yamakawa M, et al, Clinical outcomes and prognostic factors for patients with early esophageal squamous carcinoma treated with definitive radiation.
In a large, prospective study, Italian investigators randomly assigned patients with locally advanced cervical cancer to receive neoadjuvant chemotherapy followed by surgery or to undergo a standard treatment with definitive radiation.
As expected for patients receiving definitive radiation therapy, all patients had significant declines in serum PSA.
He has received international recognition for his research on the use of definitive radiation after breast conservation treatment for women with early stage breast cancer.
Salvage Cryoablation for Recurrent Localized Prostate Cancer following Definitive Radiation Therapy (from COLD Registry): A retrospective study of 277 patients with an average age of 70 (all who had previously undergone radiation therapy and the cancer had recurred) pooled from data of 27 physicians with a median follow up of 25 months.
54 year-old Hispanic female diagnosed with Stage IIB squamous cell carcinoma of the cervix in October 2000 was treated with definitive radiation therapy consisting of external beam radiation to the whole pelvis followed by high dose radiation (HDR) brachytherapy and pelvic sidewall boosts completed in August 2001.
These studies showed that survival rates were not compromised when treatment regimens that included two or three cycles of neoadjuvant cisplatin/5-fluorouracil (5-FU) were used to select patients for definitive radiation therapy.